Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00963872 · OUTCOME

Number of Patients With the Complement 3a (C3a) Unit Predominating

Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Day 180

What was measured

Efficacy of the pre-incubation of one of two umbilical cord blood (UCB) units with C3a as part of a unrelated donor double UCB nonmyeloablative transplantation in patients with high-risk hematological malignancies.

Analysis population: Two patients were unevaluable - one, because 1 bag of cord blood broke leaving only 1 cord available, and one subject never received the C3a.

Groups in this outcome

Complement Fragment 3A - Small Cell Dose

Patients who received complement fragment 3a (C3a) priming of the UCB unit with the smaller cell dose following preparation regimen and radiation.

Complement Fragment A - Larger Cell Dose

Patients who received complement fragment 3a (C3a) priming of the UCB unit with the larger cell dose.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Complement Fragment 3A - Small Cell Dose24
Complement Fragment A - Larger Cell Dose5

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Complement Fragment 3A - Small Cell Dose9Not reportedNot reportedNot reportedNot reported
Complement Fragment A - Larger Cell Dose5Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        9
      2. group Id
        OG001
        value
        5
denoms
  1. counts
    1. group Id
      OG000
      value
      24
    2. group Id
      OG001
      value
      5
    units
    Participants
description
Efficacy of the pre-incubation of one of two umbilical cord blood (UCB) units with C3a as part of a unrelated donor double UCB nonmyeloablative transplantation in patients with high-risk hematological malignancies.
groups
  1. description
    Patients who received complement fragment 3a (C3a) priming of the UCB unit with the smaller cell dose following preparation regimen and radiation.
    id
    OG000
    title
    Complement Fragment 3A - Small Cell Dose
  2. description
    Patients who received complement fragment 3a (C3a) priming of the UCB unit with the larger cell dose.
    id
    OG001
    title
    Complement Fragment A - Larger Cell Dose
param Type
NUMBER
population Description
Two patients were unevaluable - one, because 1 bag of cord blood broke leaving only 1 cord available, and one subject never received the C3a.
reporting Status
POSTED
time Frame
Day 180
title
Number of Patients With the Complement 3a (C3a) Unit Predominating
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice